Treatment of Acute Limb Ischemia with Heparin Drip

Initial Management

• The American College of Radiology recommends that patients presenting with acute limb ischemia should receive immediate anticoagulation with unfractionated heparin to prevent clot propagation and further embolism 1, 2
• The initial heparin dose should be a 60 U/kg bolus (maximum 4000 U) followed by continuous infusion at 12 U/kg/hr (maximum 1000 U/hr) 3
• The goal of heparin therapy is to rapidly achieve therapeutic anticoagulation while preparing for definitive treatment (surgical or endovascular intervention) 1

Monitoring and Titration

• The American Heart Association recommends measuring aPTT 6 hours after the initial bolus dose and adjusting the continuous IV dose according to results 4, 5
• The target aPTT should be 1.5 to 2.0 times control value, which corresponds to approximately 50-70 seconds 5
• This therapeutic range correlates with a heparin level of 0.2 to 0.4 U/mL by protamine titration or 0.35 to 0.7 U/mL by anti-factor Xa activity 5

Heparin Dose Adjustment Protocol

• The following nomogram can be used for dose adjustments based on aPTT results:
  • aPTT <35 seconds: Give 80 U/kg bolus, then increase infusion by 4 U/kg/hr 4
  • aPTT 35-45 seconds: Give 40 U/kg bolus, then increase infusion by 2 U/kg/hr 4
  • aPTT 46-70 seconds: No change (therapeutic range) 4
  • aPTT 71-90 seconds: Decrease infusion rate by 2 U/kg/hr 4
  • aPTT >90 seconds: Hold infusion for 1 hour, then decrease rate by 3 U/kg/hr 4

Duration of Therapy

• The American College of Chest Physicians recommends continuing heparin therapy until definitive treatment is performed or until transition to oral anticoagulation is complete 2
• For patients requiring surgical intervention, therapeutic anticoagulation should be maintained throughout the perioperative period unless contraindicated 1, 2

Special Considerations

• The American Heart Association recommends monitoring platelet counts daily to detect heparin-induced thrombocytopenia (HIT), which can worsen limb ischemia 3
• In patients with renal impairment, unfractionated heparin is preferred over low molecular weight heparin as it's primarily metabolized by the liver 6

Pitfalls to Avoid

• The American College of Radiology recommends not using INR to monitor heparin therapy, as aPTT is the appropriate test 4
• Immediate heparin administration is critical to prevent clot propagation, and should not be delayed while waiting for diagnostic studies 1
• Different aPTT reagents have varying sensitivities to heparin, and laboratories should establish their own therapeutic ranges 5
• Excessive anticoagulation (aPTT >90 seconds) should be avoided, as it increases bleeding risk without providing additional antithrombotic benefit 4

Adjunctive Therapy

• The American College of Radiology recommends that all patients with acute limb ischemia should be evaluated for surgical or endovascular intervention in addition to anticoagulation 1, 2
• Catheter-directed thrombolysis should be considered for patients with viable limbs when a guide wire can be passed across the lesion 1